0HHJ Stock Overview
Operates as a biotechnology company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Arch Therapeutics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.80 |
| 52 Week High | US$0.80 |
| 52 Week Low | US$0.80 |
| Beta | 3.43 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HHJ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | -0.3% |
| 1Y | n/a | -10.0% | 4.9% |
Return vs Industry: Insufficient data to determine how 0HHJ performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0HHJ performed against the UK Market.
Price Volatility
| 0HHJ volatility | |
|---|---|
| 0HHJ Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HHJ has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0HHJ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 8 | Terrence Norchi | www.archtherapeutics.com |
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds.
Arch Therapeutics, Inc. Fundamentals Summary
| 0HHJ fundamental statistics | |
|---|---|
| Market cap | US$14.85m |
| Earnings (TTM) | -US$6.41m |
| Revenue (TTM) | US$37.77k |
393.1x
P/S Ratio-2.3x
P/E RatioIs 0HHJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HHJ income statement (TTM) | |
|---|---|
| Revenue | US$37.77k |
| Cost of Revenue | US$55.01k |
| Gross Profit | -US$17.23k |
| Other Expenses | US$6.40m |
| Earnings | -US$6.41m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.35 |
| Gross Margin | -45.63% |
| Net Profit Margin | -16,980.91% |
| Debt/Equity Ratio | -75.9% |
How did 0HHJ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/03 04:01 |
| End of Day Share Price | 2023/11/06 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arch Therapeutics, Inc. is covered by 5 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raghuram Selvaraju | H.C. Wainwright & Co. |
| Michael Higgins | Ladenburg Thalmann & Company |
| Raghuram Selvaraju | Rodman & Renshaw, LLC |